Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by donkeyfeatherson Sep 30, 2021 12:41pm
182 Views
Post# 33946305

RE:Several walls are up on the sell side.

RE:Several walls are up on the sell side.Odd you'd think pointy thinkers would somehow digress from the even handedness of algos.
Meanwhile...spoken in boring monotones a la Ferris Bueller's economics classes...

We’ve all been wondering when PT would put someone in charge of some of the many business decisions like institutional investor relationships.  I thought that would be an internal team hire (bye-bye Ray), perhaps someone with an affiliation with current BOD members given the way the BOD decided to potentially enrich themselves after the motions passed at the 2021 AGM.  That way the board could point to "we are doing more work, and not simply giving a blessing to fund allocations.”  

 

Alas, we have hired another intermediary as that seems to be what we do.  Does this mean LJ and Can-O-chords lack the U.S. institutional investor reach at the “interest” scale PT and the board thinks will surface once LifeSci works their awareness campaign of the pouch?  Honestly, after all these years, which potential investors-at-(large)scale would want to do a PP or some other direct investment in Sernova over participating in the VC markets where they have way more control?

 

Yes, a nod to keeping the lines of communication open, but as the scientific milestones ARE reached, do we have anyone in-house getting cash infusion deals done?  Anyone?  Anyone?
DF

<< Previous
Bullboard Posts
Next >>